143 | REAL‐WORLD OUTCOMES OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) FOR THE TREATMENT OF RICHTER TRANSFORMATION TO LARGE B‐CELL LYMPHOMA (RT‐LBCL)
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
10.1002/hon.70093_143